Browse by category

5HT2A antagonist to combat fatty liver disease

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a burgeoning global health concern, posing a significant threat to...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

21 hours ago

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

22 hours ago

Racial and ethnic groups face barriers to obtaining OMMs

22 hours ago

Weekly Digest